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Abstract
We propose a culture-free approach to osteochondral repair 
with minced autologous cartilage fragments loaded onto 
a scaffold composed of a hyaluronic acid (HA)-derived 
membrane, platelet-rich fibrin matrix (PRFM) and fibrin 
glue. The aim of the study was to demonstrate in vitro 
the outgrowth of chondrocytes from cartilage fragments 
onto this scaffold and, in vivo, the formation of functional 
repair tissue in goat osteochondral defects. Two sections 
were considered: 1) in vitro: minced articular cartilage 
from goat stifle joints was loaded onto scaffolds, cultured 
for 1 or 2 months, and then evaluated histologically and 
immunohistochemically; 2) in vivo: 2 unilateral critically-
sized trochlear osteochondral defects were created 
in 15 adult goats; defects were treated with cartilage 
fragments embedded in the scaffold (Group 1), with the 
scaffold alone (Group 2), or untreated (Group 3). Repair 
processes were evaluated morphologically, histologically, 
immunohistochemically and biomechanically at 1, 3, 6 
and 12 months. We found that in vitro, chondrocytes from 
cartilage fragments migrated to the scaffold and, at 2 
months, matrix positive for collagen type II was observed 
in the constructs. In vivo, morphological and histological 
assessment demonstrated that cartilage fragment-loaded 
scaffolds led to the formation of functional hyaline-like 
repair tissue. Repair in Group 1 was superior to that of 
control groups, both histologically and mechanically. 
Autologous cartilage fragments loaded onto an HA/
PRFM/fibrin glue scaffold provided a viable cell source 
and allowed for an improvement of the repair process of 
osteochondral defects in a goat model, representing an 
effective alternative for one-stage repair of osteochondral 
lesions.
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Cartilage injuries are commonly found in orthopaedic 
surgery, and spontaneous healing of osteochondral lesions 
leads to the formation of fibrocartilage, a type of functional 
repair tissue that has different biochemical composition 
and inferior biomechanical properties from those of 
hyaline articular cartilage. Thus, finding a viable cell 
source and a suitable scaffold are significant milestones 
for cartilage repair, and the presence of chondrogenic 
cells in cartilage defects seems to be a key feature for 
good clinical and histological results. The most commonly 
available treatments to enhance the quality of repair of 
symptomatic deep cartilage and osteochondral lesions 
include: 1) bone marrow stimulation (microfractures, 
MF) (Mithoefer et al., 2005); 2) osteochondral autograft 
transplantation (OAT) (Bobic, 1999) (Gudas et al., 2012); 
and 3) autologous chondrocyte implantation (ACI) 
(Peterson et al., 2010). MF and single-plug OAT are 
usually implemented for small chondral and osteochondral 
defects (< 1-2 cm2), while for larger lesions, multiple OAT 
and ACI are both preferable treatment options (Bekkers 
et al., 2009; De Windt et al., 2012).
 Bone marrow stimulation through microfractures is the 
simplest and most economic one-step approach, but often 
results in the generation of mixed fibrocartilage tissue that 
tends to degenerate over time (Hunziker, 1999a; Shapiro 
et al., 1993). Osteochondral autograft transplantation 
facilitates the formation of more homologous tissue 
at the lesion site, but raises concerns about donor-site 
morbidity, technical difficulties, and integration of the 
graft at the interface with the receiving site. Indeed, with 
OAT, mature hyaline cartilage is transferred from an area 
that bears less weight to the defect site, but the technical 
difficulties to obtain a careful restoration of the curvature 
of the articular surface are limiting factors. Moreover, in 
larger defects, multiple plugs are needed, and close contact 
with the surrounding host bone could be incomplete, 
compromising plug integration. Osteochondral allografts 
could overcome some of these limitation, but fresh graft 
availability and high costs are still limiting factors of this 
procedure (Gomoll et al., 2010). Autologous chondrocyte 
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implantation leads to a hyaline-like regenerative tissue with 
better histological and clinical results than microfractures 
as well as durable properties. It can be used both with 
a chondrocyte suspension or with a 3-D pre-loaded 
membrane (MACI, Hyalograft C and others), and 
combined procedures are being exploited for deeper 
defects, involving transplantation of trabecular bone in 
association with cell transplantation (Bartlett et al., 2005). 
However, there are still several limitations to autologous 
chondrocyte implantation, as multiple surgical procedures 
are required and costly chondrocyte culture is needed in 
order to expand cells in vitro before implantation.
 Recently, tissue engineering is developing new 
alternatives to overcome these limitations and new one-
stage methods have been investigated in order to obtain 
controlled differentiation of repair tissue with good 
functional properties and valuable histological features, 
avoiding cell manipulation, multiple surgical procedures, 
high costs and major patient morbidity. The autologous 
matrix-induced chondrogenesis (AMIC) technique is a 
one-step procedure for focal chondral and osteochondral 
defects, combining subchondral microfractures with a 
collagen I/III membrane secured with fibrin glue or sutures. 
This enables bone marrow cell adhesion, optimising 
fibrocartilaginous repair (Benthien and Behrens, 2011); 
platelet-rich plasma gel can also be combined to enhance 
repair processes (Dhollander et al., 2010). Maioregen 
(Fin-Ceramica Faenza S.p.A., Faenza-Italy) is a thick, 
nanostructured biomimetic collagen and hydroxyapatite 
scaffold used for treatment of large osteochondral lesions. 
As in the AMIC technique, cell migration from the 
surrounding host bone and bone marrow is required in order 
to colonise the scaffold and achieve functional repair (Kon 
et al., 2010a; 2010b). Osteochondral morselised grafts 
have been proposed as a “paste” without any scaffold for 
one-stage repair of full thickness articular cartilage lesions 
and osteochondral defects, both in animal and human 
studies (Stone et al., 2006; Mahadev et al., 2001). This 
solution implies an undifferentiated mixed cell source from 
cartilage, bone and blood for the repair process (Stone 
et al., 2006). Bone marrow concentrate and platelet gel 
have also been recently combined with a hyaluronic acid 
membrane for one-step repair of osteochondral lesions 
of knees and ankles (Buda et al., 2010; Giannini et al., 
2009). Results and effectiveness of all these procedures 
are promising, but still under investigation.
 To preserve the advantages of chondrocyte therapy, 
whilst at the same time reducing cell manipulation, 
cartilage fragments have been also investigated in animal 
models as well as a human trial, as being a suitable cell 
source for one-step cartilage repair – in association with 
collagen membranes or polydioxanone mesh (cartilage 
autograft implantation system, CAIS) (Cole et al., 2011; 
Frisbie et al., 2009; Lu et al., 2006). The rationale of this 
Fig. 1. Study design. In vitro study: cartilage fragments were harvested from goat knees (A); minced cartilage 
fragments were loaded onto the scaffold (B); In vivo study: cartilage fragments were harvested from goat knees 
(C), minced, loaded onto the scaffold (D) and used as a cell source for the repair of osteochondral defects in goat 
knees (study group A). FG, fibrin glue; HA, hyaluronic acid; PRFM, platelet-rich fibrin matrix.
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repair technique is the spontaneous ability of chondrocytes 
to migrate from the cartilage chips and proliferate into 
the scaffold. Cartilage fragmentation greatly increases 
tissue surface area and maximises the number of cells 
that can then interact with the three-dimensional structure 
of the scaffold. Fragmentation also separates cell-matrix 
bonding and promotes a “motile phenotype”, eliciting cell 
outgrowth toward the surrounding environment (Reindel 
et al., 1995).
 This study proposes a one-stage culture-free 
chondrocyte approach to osteochondral repair, using 
autologous cartilage fragments as a cell source, loaded 
onto an absorbable scaffold composed of a hyaluronic 
acid-derived membrane (Hyaff-11), autologous platelet-
rich fibrin matrix (PRFM, Cascade system) and injectable 
fibrin glue. Based on the results from previous investigators 
on the chondrogenic potential of fresh minced cartilage 
chips (Cole et al., 2011; Frisbie et al., 2009; Lu et al., 
2006), the present study aims to investigate (Fig. 1): (a) 
in vitro – the outgrowth of chondrocytes derived from 
chondral fragments, obtained by mechanical fragmentation 
of articular cartilage, loaded onto the aforementioned 
absorbable scaffold; and (b) in vivo – the repair efficacy 
of the experimental composite in goat trochlear lesions, a 
clinically relevant large animal model. For this purpose, 
deep osteochondral defects were treated with autologous 
cartilage fragments loaded onto the absorbable scaffold; 
other defects were either treated with the scaffold alone or 
left untreated for control groups.
Materials and Methods
Approvals were obtained both from the Ethical Committee 
of the MBC (Molecular Biotechnology Centre), University 
of Torino, and from the Animal Care and Use Centre 
(CISRA), Faculty of Veterinary Medicine, University of 
Torino.
Method for platelet-rich fibrin matrix (PRFM ) 
preparation
A goat blood sample was collected preoperatively (10 mL) 
in order to obtain autologous PRFM (Cascade® Autologous 
Platelet System, MTF Sports Medicine, Cascade Medical 
Enterprises, Wayne, NJ, USA) (Hall et al., 2009; Castillo 
et al., 2011). Briefly, according to the manufacturer’s 
instructions, 10 mL of peripheral goat blood were collected 
in a supplied sterile blood collection/separation tube (Tube 
1). Mean concentration of original platelets was 348 x 
103 platelets/µL (range 166-504). Tube 1 was centrifuged 
at 1100 g for 6 min to obtain platelet rich plasma (PRP). 
Following centrifugation, the supernatant on top of the 
separation gel was composed of PRP, whereas red and 
white blood cell fractions were located below the gel. 
PRP supernatants were transferred to a second tube (Tube 
2), containing a calcium chloride additive (0.25 mL 1 M 
CaCl2). Tube 2 was centrifuged for 15 min at 1450 g, and 
a gel was obtained corresponding to a leukocyte-poor 
PRFM of 1.5 mL containing approximately 5x platelet/
fibrin, according to the manufacturer (Simon et al., 2009).
In vitro study
Constructs were prepared with goat cartilage fragments. 
Articular cartilage pieces were harvested from femoral 
trochleae of 7 adult female Roccaverano goats during the 
in vivo part of the experiment, from the animals assigned 
to control groups.
 Care was taken in order to remove all debris of the 
calcified cartilage and the subchondral bone from the 
specimens. Cartilage pieces from both trochlear defects 
of the same animal were pooled together, rinsed with 
sterile saline, transferred to a Petri dish and manually 
minced into small cuboidal fragments (less than 1 mm3) 
in sterile conditions with a sharp No. 15 scalpel in the 
presence of phosphate-buffered saline (PBS) (Celbio, Pero, 
Milano, Italy). A non-woven esterified HA-derivative felt 
(Hyaff-11, FIDIA Advanced Biopolymers, Abano Terme, 
Italy) was trimmed to pieces of 0.7 cm2. Two sheets were 
layered in a culture dish. Approximately 15 mg of cartilage 
fragments were evenly seeded onto the membrane and 
were retained with a thin coating of approximately 50 µL 
of fibrin glue (Tissucol, Baxter AG, Vienna, Austria) using 
thrombin (400-625 units/mL) that was previously diluted 
to 1:4 with calcium chloride (36-44 μmol/mL). A 200 µL 
volume of PRFM (Cascade) was then placed on top of the 
cartilage fragments. A total of 6 constructs per animal were 
prepared.
 All constructs were cultured at 37 °C in a humidified 
atmosphere containing 5 % CO2. Culture medium 
contained high glucose (4500 mg/L) DMEM (Celbio, 
Pero, Milan, Italy) with 10 % foetal bovine serum (Sigma 
Chemical Co., St. Louis, MO, USA), HEPES (10 mM) 
(Sigma), nonessential amino acids (0.1 mM) (Sigma), 
L-proline (20 ng/mL) (Sigma), ascorbic acid (50 µg/mL) 
(Sigma), 10,000 units Penicillin, 10 mg Streptomycin in 
0.9 % sodium chloride (Sigma). Culture medium was 
changed three times per week.
 After 15 d, 1 month and 2 months, constructs were 
retrieved from cultures, fixed in formalin, embedded in 
paraffin, and processed for histological analysis. Tissue 
sections were stained for Haematoxylin/Eosin and Alcian 
Blue. Type I (MAB3391, Millipore, Milan, Italy) and II 
collagen (MAB-10200, Immunological Science, Rome, 
Italy) immunohistochemistry was also performed on the 
specimens retrieved after 1 and 2 months.
In vivo animal study
18 adult female Roccaverano goats were used in this study. 
10 mL blood samples were collected preoperatively to 
obtain autologous PRFM (Cascade®), as described above. 
All animals were anaesthetised as follows: 10 mg/100 mL 
Acepromazine Maleate – Prequillan (Fatro S.p.A., 
Bologna, Italy ) at the dosage of 0.1 mg/kg 1 h before 
surgery; 10 mg/20 mL Propofol – Rapinovet (Intervet 
Italia Srl, Milano, Italy) at the dosage of 7 mg/kg at the 
induction of anaesthesia. After induction, anaesthesia 
was maintained with isoflurane – Isoflurane-vet 250 mL 
(100 % isoflurane) (Merial Italia S.p.A., Padova, Italy) 
for a percentage of 1-2.5 % of isoflurane inspired during 
the procedure and buprenorphine – Temgesic iv (Shering 
Plough S.p.A., Milano, Italy) 0.3 mg/mL at the dosage of 
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0.01 mg/kg. At the end of anaesthesia, postoperative pain 
management was instituted with buprenorphine – Temgesic 
im (Shering Plough S.p.A.) 0.3 mg/mL at the dosage of 
0.01 mg/kg. Prophylactic antibiotic therapy was instituted 
as follows: tetracycline – Terramicina-ossitetracycline 
92.7 mg/mL (Pfizer Italia SRL, Latina, Italy ) at the dosage 
of 10 mg/kg the day before the operation and every 24 h 
up to the sixth postoperative day; cefazolin – Cefazolina 
im 1 g/4 mL (Mylan S.p.A., Milano, Italy) at the dosage 
of 20 mg/kg 1 h before surgery and every 12 h up to the 
second postoperative day.
 Defects were prepared by exposing the femoral 
trochlea using a medial arthrotomy, thus dislocating the 
patella laterally. Unilateral trochlear models consisted 
of two large full-thickness osteochondral defects (7 mm 
diameter; 3.5 mm depth), created in the central trochlear 
area of the right stifle joints with a minimum of 5 mm of 
separation between the 2 defects. In each goat, cartilage 
was collected from the defect areas before defect creation 
and manually minced in the presence of PBS, obtaining 
fragments of less than 1 mm3. Cartilage fragments were 
then pooled together to be used both for the in vitro culture 
and for the in vivo autologous implant in the experimental 
group (Group 1). A 7 mm diameter manual drill was used to 
create the defects. A slow and progressive manual drilling 
was performed for each defect. Debris were removed 
by the advancing of the spiral drill and with the help of 
multiple lavages with physiological solution during and 
after the drilling procedure. This allowed for a controlled 
and standardised penetration of the drill and avoided any 
major heat generation around the defect surface and any 
debris build-up. Consequently, the structural integrity and 
vitality of the bone and vessels surrounding the defect site 
was preserved, as evidenced by the absence of any fracture 
of bone at the rim of the lesion and by the amount of blood 
that appeared at the bottom of the defect site during the 
final drilling phase.
 The dimensions chosen in this model were based on 
prior studies (Frisbie et al., 2006; Jackson et al., 2001) 
that showed that osteochondral defects of 6 mm diameter 
do not spontaneously heal. A depth of 3.5 mm enabled 
the removal of approximately 2-2.5 mm of underlying 
subchondral bone (Hunziker, 1999b; Ahern et al., 2009).
 A total of 36 defects (for all goats used in the study) 
were created. Animals were randomised into 3 different 
groups: cartilage fragments plus scaffold (Group 1, 
experimental group), scaffold alone (Group 2), empty 
unfilled defects (Group 3) (Fig. 2).
 Goat defects in Groups 1 and 2 were filled as follows: 
the defect was dried with a sterile sponge, and 90 µL of 
autologous PRFM was manually placed at the bottom. 
In Group 1, autologous cartilage fragments, harvested 
from the two trochlear areas and pooled together, were 
evenly distributed at the surface of the autologous PRFM 
at a density of approximately 20 mg/cm2, based on 
previous studies (Lu et al., 2006; Frisbie et al., 2009). 
Approximately 20 µL of fibrin glue (Tisseel, Baxter AG, 
Vienna, Austria; with thrombin previously diluted to 1:4 
with calcium chloride) was added to stabilise the construct. 
A sheet of Hyaff-11 (diameter 7 mm) was then added to seal 
the defect. Manual pressure on the surface of the constructs 
was applied to further stabilise the scaffold until the fibrin 
glue polymerisation was completed and the implant surface 
was even with the surrounding trochlear area. The wound 
was closed and a soft bandage was bound on the wound for 
the first 4-5 d. Postoperatively, all animals were allowed 
free-loading activity and free cage activity, and they were 
kept in a properly cleaned animal care facility. A single 
stall (5 m x 5 m) was used to host each animal for the 
first 2 postoperative weeks; all animals were then kept 
Fig. 2. Study groups. Experimental groups were prepared with cartilage fragments: Group 1) cartilage fragments 
loaded onto the scaffold; Group 2) scaffold alone; Group 3) empty defect. FG, fibrin glue; HA, hyaluronic acid; 
PRFM, platelet-rich fibrin matrix.
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together in a common environment (5 m x 15 m) up to the 
end of the follow-up period. Spontaneous rest and reduced 
movement of the animals were observed for the first 5-7 d. 
Generally, no sign of limping was observed after 8-10 d 
following surgery. We did not observe any difference of 
postoperative behaviour among the animals. Three goats 
died postoperatively and were excluded from the study. 
The remaining animals were humanely euthanised after 1 
month (3 goats, 2 defects per group), 3 months (3 goats, 2 
defects per group), 6 months (3 goats, 2 defects per group) 
and 12 months (6 goats, 4 defects per group). All animals 
were euthanised, following anaesthesia, using Tanax bottle 
50 mL (Intervet Italia Srl) at the dosage of 0.1 mL/kg by 
intracardiac injection.
 Total joint health was assessed by gross-morphological 
evaluation, by observing the repair tissue filling, the 
presence of osteophytes and the inflammatory changes 
of the synovial membrane. At 1 year, the International 
Cartilage Repair Society (ICRS) form (ICRS Cartilage 
Repair Assessment) was used to collect macroscopic 
characteristics of the repair tissue (Kaul et al., 2012; 
Brittberg and Winalski, 2003) and each stifle joint was 
evaluated with the macroscopic scores of Little (Little et 
al., 2010).
 For histological assessment, the distal femur was excised, 
fixed in 10 % formalin and decalcified. Samples were then 
paraffin-embedded, sectioned with a microtome (5 µm) 
and stained with Haematoxylin/Eosin and Alcian blue. 
Samples were also processed for immunohistochemistry 
analysis for type I and II collagen. Type II collagen 
immunohistochemistry was performed with MAB-10200 
(Immunological Science). Each slide was blindly examined 
under a light microscope by 2 blinded observers. Samples 
were semi-quantitatively graded using the modified ICRS 
score (Liu et al., 2006), the modified O’Driscoll scale 
(Frisbie et al., 2009), and the microscopic scores of Little 
(Little et al., 2010). These scoring systems were based on 
the percentage of defect filling, articular surface continuity, 
restoration of osteochondral architecture, repair tissue 
integration, cellular morphology of articular cartilage 
regeneration, and matrix staining.
 The superficial zone of repair tissue from 1 year 
specimens from Groups 1, 2 and 3, was biomechanically 
tested by nanoindentation (Franke et al., 2007). For positive 
Fig. 3. Microscopic analysis of cartilage fragment-loaded constructs from goat femoral trochlea at 1 month (a,b,c) and 
2 months (d,e,f); (a,d) haematoxylin-eosin staining; (b,e) Alcian Blue staining; (c,f) collagen type II immunostaining; 
the asterisk (*) marks the cartilage fragments in a and d; the arrows indicate the presence of neo-matrix positive for 
collagen type II, produced by the chondrocytes and located within the scaffold in c and f. Histological figures were 
obtained by combining different microscopic images.
1 mm
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controls, mechanical tests were also performed on trochlear 
cartilage samples from the contralateral stifle joint of Group 
1 goats. From treated goat stifle joint, a representative 
osteochondral sample corresponding to the inferior half 
of the defect area was prepared using a miniature rotating 
saw. The same area was isolated from the trochleae of 2 
contralateral stifle joints of Group 1 goats. Samples were 
transferred to PBS to prevent drying and stored at 4 °C. 
Testing was performed within 72 h from harvesting. 
Nanoindentation was performed with a Nanoindenter XP 
(MTS, Eden Prairie, MN, USA) with a diamond indenter 
(Berkovich diamond tip) at room temperature. Samples 
were placed in a plastic chamber with the cartilage surface 
perpendicular to the indenter direction and secured to a 
metallic support. They were kept hydrated with saline prior 
to testing. The Berkovich tip was driven onto the specimen 
surface and the applied force and displacement obtained 
were recorded. Material properties were calculated from 
the load and depth of indentation. Hardness (H) and 
Young’s modulus (E) were calculated as a function of 
load and depth during the unloading phase of testing, with 
a maximal load of approximately 75 mN and a maximal 
depth of 100 µm. Sample fractures of Groups 2 and 3 were 
observed beyond 40 µm of Berkovich tip penetration; 
this compromised Young’s modulus determination during 
the unloading phase for Groups 2 and 3. Mean values of 
Young’s modulus (E) were then calculated for all samples 
on the loading curves, in a range of 1-40 µm depth. This 
allowed for a comparative evaluation between groups, 
although in a limited range of tip penetration.
Statistical analysis
All data in text and figures are provided as means ± SD. 
Results were analysed by a one-way Analysis of Variance 
(ANOVA) and Tukey’s test. A p < 0.05 was considered 
statistically significant.
Fig.4. Macroscopic and microscopic views of repair tissue at 1 month post-implantation. Group 1: a,b,c; Group 2: 
d,e,f; Group 3: g,h,i. Macroscopic views (a,d,g); sections of the defect area stained with H/E (b,e,h), and Alcian Blue 
(c,f,i). Histological figures e and f were obtained by combining different microscopic pictures. Cell infiltration of 
the scaffold can be observed in all groups, more markedly in Groups 1 and 2. In Group 1, cell are visible around the 
cartilage fragments, which were located at the deeper zone of the defect under the HA sheet, suggesting the potential 
contribution of cartilage chips to the repair. Cells are also present at the upper layer of the defect, likely deriving 
from the surrounding synovial tissue and from the cartilage at the perimeter of the defect. Cells are also visible both 
infiltrating the bottom of the defect and inside the scaffold, likely deriving from the bone marrow underneath and 
around the defect walls. In all three groups, the lowest amount of cells corresponded to the central zone of the defects. 
No clear matrix deposition was observed in any group. 
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Results
In vitro study
Chondrocyte outgrowth into scaffolds was evident at 
15 d (data not shown) and increased at 1 and 2 months. 
Constructs loaded with cartilage fragments showed high 
cellularity after 1 month, while intense neo-matrix was 
evident within scaffold structures after 2 months. Migrated 
chondrocytes showed a rounded shape, surrounded by 
neo-matrix, after 2 months. The newly formed tissue 
between the fragments was positive for collagen type II 
immunostaining at 2 months (Fig. 3) and showed a weak 
positivity for collagen type I immunostaining.
In vivo animal study
Some major adverse events occurred during the in vivo 
study. Three animals died between day 30 and day 45 
postoperatively due to acute infectious enteritis, despite the 
antibiotic prophylaxis, and were excluded from the study. 
Autopsies performed at the Animal Care Institute (CISRA) 
on the 3 goats did not show signs of thromboembolism 
in the mesenteric vessel. A total of 15 animals therefore 
completed the follow-up.
 Three goats were euthanised at 1 month (with a total 
of 6 defects, 2 defects per group), 3 goats at 3 months 
(6 defects, 2 defects per group) and 3 goats at 6 months 
(6 defects, 2 defects per group) in order to qualitatively 
evaluate the repair process. Additionally, in order to 
perform semi-quantitative evaluation (ICRS, O’Driscoll 
and Little score) and mechanical testing (nanoindentation), 
6 goats were euthanised at 1 year (12 defects, 4 defects per 
group).
 At 1 month (Fig. 4), gross-morphological evaluation 
on specimens showed a depressed surface of repair tissue, 
pale in appearance, particularly marked in Groups 2 and 
3. Gross appearances of Group 1 and 2 were similar due 
to the presence of the scaffold, still largely unresorbed at 
the surface of the defect site. Mild synovial changes were 
observed in all operated stifle joints. The irregular repair 
tissue corresponded histologically to a cell infiltration of 
the scaffold in Groups 1 and 2. Cells were scarce at the 
central zone of the defect in all three groups.
 Various cells were observed as contributors to the 
repair. These were seen around the cartilage fragments, 
at the upper layer and at the bottom of the defect, along 
with cells visible inside the scaffold. No clear matrix 
Fig. 5. Macroscopic and microscopic view of repair tissue at 3 months post-implantation. Group 1: a,b,c; Group 
2: d,e,f; Group 3: g,h,i. Macroscopic views (a,d,g); sections of the defect area stained with H/E (b,e,h), and Alcian 
Blue (c,f,i). Histological figure i was obtained by combining different microscopic pictures. The repair tissue is 
irregular and poorly differentiated in all groups. A widespread cell infiltration is visible in all zones of the scaffold 
in Groups 1 and 2, the former showing higher cellularity at defect sites and inflammatory tissue around the defect 
area. Interposing areas of neo-matrix positive for type II collagen can be observed in Group 1 among the fragments.
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deposition was observed in any group. In Group 1, cartilage 
fragments, which were located at the deeper zone of the 
defect, appeared under the HA sheet, surrounded by a 
large number of cells, infiltrating both the space between 
the fragments and the lower part of the HA sheet. Repair 
tissue of untreated defects was similar to the early healing 
process in deep osteochondral lesions in goat models, with 
the formation of fibrous tissue, as reported in the literature 
(Jackson et al., 2001). Neither fracture sign nor major 
vascular compromise in the host bone were observed in 
any group.
 At 3 months (Fig. 5), gross-morphological evaluation in 
all groups continued to show an uneven and depressed layer 
of repair tissue. At the periphery of the defect, repair tissue 
was thicker in Group 1, showing a white colour similar to 
the surrounding cartilage. Minor synovial changes were 
observed in all groups. Histologically, the repair tissue 
was still irregular and poorly differentiated in all groups. 
A widespread cell infiltration was observed in all zones of 
the scaffold in Groups 1 and 2.
 Group 1 showed high cellularity at defect sites, with 
some inflammatory tissue around the defect area; cartilage 
fragments were still detectable, although the cell migration 
created patchy over-stained interposing areas of matrix 
positive for type II collagen among the fragments. In 
empty defects (Group 3) and in Group 2 samples, these 
areas were not detectable. Repair tissue showed a greater 
inflammatory reaction in Group 2 around the defect area, 
while in specimens of Group 3, a remodelling of the natural 
fibrin clot was observed, with formation, in some cases, of 
a central cyst-like structure, as also observed in previous 
studies (Jackson et al., 2001).
 At 6 months (Fig. 6), the repair process was still 
macroscopically irregular and depressed in all groups. 
Small osteophytes and surface irregularities were observed 
in all stifle joints along with mild macroscopic inflammatory 
changes of the synovial membrane. Immature fibrous tissue 
and areas of hypercellularity were observed at histological 
evaluation in all groups In Group 1, cartilage fragments 
were scarcely detectable; areas of neo-matrix positive for 
type II collagen were observed at the superficial and central 
portions of the defects, with staining similar to that of the 
native cartilage at the border of the defect. In Groups 1 and 
2, remnants of the Hyaff-11 membrane were still present. 
In the control Groups 2 and 3, no collagen type II-positive 
areas were observed.
 After 1 year (Fig. 7), gross morphological evaluation 
showed better quality repair tissue in defects treated with 
Fig. 6. Macroscopic and microscopic view of repair tissue at 6 months post-implantation. Group 1: a,b,c; Group 
2: d,e,f; Group 3: g,h,i. Macroscopic views (a,d,g); sections of the defect area stained with H/E (b,e,h), and 
immunohistochemistry for collagen type II (c,f,i). Immature fibrous tissue and areas of hypercellularity are present 
in all groups. In Group 1, neo-matrix positive for type II collagen is visible at the superficial and central portions of 
the defects, along with remnants of the Hyaff membrane, while cartilage fragments are scarcely detectable.
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cartilage fragments along with scaffolds (Group 1). Repair 
tissue was white and mostly even with the surrounding 
cartilage, although some fissures and small depressed areas 
were observed at the periphery of the defects. In Groups 2 
and 3, some even areas with whitish repair tissue were also 
present, but most of the defect site was filled with rough, 
uneven tissue. Synovial tissue proliferation and osteophyte 
formation were evaluated following the macroscopic 
scoring method of Little (Little et al., 2010). No major 
synovial reactions (i.e score > 1) were detected in any 
of the three groups, while mild osteophyte development 
(i.e. score = 1) was observed around the trochlear areas 
and around the medial femoral condyles in most of the 
specimens of the three groups. However, no significant 
differences were observed among all stifle joints of the 
experimental animals regardless of the treatment used.
 Evaluation of the repair tissue showed higher scores 
for defects treated with cartilage fragments along 
with scaffolds (Group 1), both macroscopically and 
microscopically (Fig. 8). Macroscopic ICRS Cartilage 
Repair Assessment showed significant differences between 
Group 1 and both control groups in the “Degree of Defect 
Repair” and in the “Macroscopic Appearance”, while no 
significant differences were noticed between untreated 
defects (Group 3) and defects treated with scaffolds alone 
(Group 2). The same statistical trend was observed in 
the modified microscopic ICRS score, in the O’Driscoll 
microscopic score, and in the microscopic score of Little. 
In the latter, significant difference between Group 1 and 
both control groups was observed in section A (Structure), 
section D (Interterritorial Toluidine blue) and section E 
(Tidemark/calcified cartilage/subchondral bone), while in 
section B (Chondrocyte density) a significant difference 
was noticed between Groups 1 and 3 and between Groups 
2 and 3.
 Repair tissue of Group 1 showed: i) some features 
of hyaline-like cartilage with normal to moderate matrix 
staining (Fig. 7Ab and d); ii) the presence of type II 
collagen upon immunostaining in the superficial layer 
of the repair tissue (Fig. 7Af); iii) the presence of type 
I collagen in the newly formed subchondral bone, along 
with some traces also in the upper layer of the cartilaginous 
repair tissue (Fig. 7Ae); iv) restoration of osteochondral 
complexes and, in some areas, columnar arrangement of 
chondrocytes (Fig. 7Ac). Nevertheless, some irregular 
bonding adjacent to the healthy cartilage was observed.
 Treatment with scaffolds alone (Group 2) mainly 
led to the formation of central fibrous-fibrocartilaginous 
tissue with some remnants of the Hyaff membrane in the 
central areas of the defects (Fig. 7B). Peripheral areas 
of cartilage matrix were often present and were positive 
for type II collagen, suggesting a centripetal repair from 
surrounding healthy cartilage. Inflammatory infiltration 
was still detected around the Hyaff-11 membrane; and 
bone was present at the bottom of the defects, around the 
residual scaffold.
 Empty defects were filled with a homogeneous 
fibrocartilage repair tissue without columnar organisation 
(Fig. 7C); some irregular gaps at defect borders were 
observed, occasionally with the exposure of subchondral 
bone. Group 3 fared better than Group 2 for subchondral 
bone restoration, but lacked any type II collagen-positive 
matrix at the peripheral areas.
 Nanoindentation of goat samples after 1 year 
demonstrated interesting differences between groups (Fig. 
9). Group 1 behaved in a considerably different manner 
from control Groups 2 and 3. From the unloading curve, 
hardness of Group 1 was greater than Groups 2 and 3, 
and mean values were closer to healthy trochlear cartilage 
than any of the control groups, although mean hardness 
(H) of healthy cartilage was significantly different from 
that of all groups (p < 0.05). Young’s modulus of Group 1 
was similar (p > 0.05) to healthy cartilage. Mean Young’s 
modulus, as determined from the loading curves, revealed 
similar findings. A significant difference (p < 0.05) was 
still observed between mean values of healthy cartilage 
and mean values of all three Groups, but the group treated 
with cartilage fragments loaded onto scaffolds (Group 1) 
reached values superior to those of control Groups 2 and 
3 (p < 0.05), and was the most similar to that of healthy 
cartilage (Fig. 9).
Discussion
In the present study, we have demonstrated that long-
term osteochondral repair is made feasible using cartilage 
fragments embedded in a hyaluronic acid/PRFM/fibrin 
glue scaffold in a goat model. This method is distinct from 
aforementioned studies because it relies on a hyaluronic 
acid, fibrin glue and autologous PRFM scaffold to 
obtain chondrocyte migration from autologous cartilage 
fragments.
 The hyaluronic acid-derived membrane, Hyaff-11, 
was chosen for its well-known chondrogenic and adhesive 
properties (Cavallo et al., 2010; Kon et al., 2009). In this 
Fig. 7. (previous page) Macroscopic and microscopic view of repair tissue at 1 year post-implantation. A: Group 1, 
B: Group 2; C: Group 3. Macroscopic views (a). Sections of the defect area stained with H/E (b,c), Alcian Blue (d), 
and immunohistochemistry for collagen type I (e) and type II (f). Histological figures Cb and Cd were obtained by 
combining different microscopic pictures. Some features of hyaline-like cartilage can be observed in repair tissue 
of Group 1, as the presence of type II collagen upon immunostaining in the superficial layer of the repair tissue, the 
presence of type I collagen in the newly formed subchondral bone, the restoration of osteochondral orientation, and, 
in some areas, the columnar arrangement of chondrocytes. Fibrous-fibrocartilaginous tissue is predominant in Group 
2, along with remnants of the Hyaff-11 membrane in the central areas of the defect surrounded by inflammatory 
infiltration; incomplete subchondral bone restoration is also visible. Group C repair is mainly constituted by a 
homogeneous fibrocartilage repair tissue without columnar organisation surrounding a layer of newly formed 
subchondral bone; neomatrix in the upper layer lacks any type II collagen-positivity.
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model, it also worked well in conjunction with fibrin glue 
for coverage of the defect, and no membrane dislodgements 
were observed. A single Hyaff-11 membrane was sufficient 
to cover the defects during the in vivo experiment. On 
the other hand, in the in vitro study, a single layer was 
inadequate to contain all migrating cells, as during the 
early set-up phase of the study we observed a considerable 
number of cells at 1 month attached to the plastic dishes. 
Therefore, two sheets of HA membrane were used as a 
barrier in the study design, in order to avoid any significant 
cell migration from the construct to the Petri dish.
 The Cascade-PRFM was chosen as a bioactive 
mouldable component of the scaffold. The Cascade 
technique has several advantages. It enables reduction 
of the damage to platelets during extraction, due to the 
absence of bovine thrombin in the production process 
(Carroll, 2005), producing a gel-like matrix with 
significantly higher number of platelets (approximately 
5x) (Simon et al., 2009) in the end-product, compared to 
that of peripheral blood. The high capture efficiency of this 
commercial system was convenient for the design of the 
in vivo animal study, because it allowed for using smaller 
blood volumes compared to that of other commercial 
systems (i.e. Biomet GPS III) (Castillo et al., 2011). This 
end-product is a platelet derivative with low content of 
leukocytes; this was also considered favourable, as data 
from the literature suggested that anabolism requires low 
levels of leukocytes and the presence of high leukocytes 
concentration may increase catabolic signalling molecules 
(Sundman et al., 2011). Additionally, this PRFM contains 
higher concentrations of growth factors (e.g. TGF-β1) 
compared to simple blood clots, and allows for temporary 
defect filling while delivering mitogenic factors from 
autologous platelets up to several days after the preparation, 
as shown in previous studies (Visser et al., 2010). These 
factors have also been shown to enhance tendon repair in 
vivo in animal models (Sarrafian et al., 2010). Moreover, 
anti-inflammatory properties have been recently attributed 
to the presence of other agents, for example the hepatocyte 
growth factor (Bendinelli et al., 2010). Furthermore, the 
end-product is a material that can be moulded in order to 
facilitate surgical application as the high fibrin content 
makes the matrix a natural scaffold with the ability to assist 
the ultimate repair of the lesions (Sánchez et al., 2007).
 For the scaffold preparation, a small quantity of 
commercial fibrin glue (Tisseel, Baxter) was applied 
in order to stabilise cartilage fragments under the HA 
membrane. This was supported by in vitro observations 
showing the effect of fibrin glue in facilitating the migration 
of chondrocytes out of cartilage fragments in the first 
phases of scaffold colonisation. A 1:4 thrombin dilution 
compared to the original commercial preparation was 
chosen in order to obtain a large pore three-dimensional 
structure; this created spatial continuity between fragments, 
thus enabling free movement of cells. The fibrin glue can 
therefore be considered as a wrapping material for the 
cartilage chips and a bridging material between the HA-felt 
and the PRFM. As shown in other in vivo studies (Deponti 
et al., 2012; Lewis et al., 2009; Peretti et al., 2006; Peretti 
et al., 2001; Peretti et al., 2000), we did not observe any 
major inflammatory reactions in animal models, supporting 
the use of fibrin glue as a component of the scaffold.
 In this study, cartilage fragments were harvested in each 
goat, during surgery, from the cartilage layer surrounding 
the two trochlear areas corresponding to the full-thickness 
osteochondral defect sites. They were pooled together and 
Fig. 8. Semi-quantitative histology scores using the modified ICRS score (Liu et al., 2006) and the modified O’Driscoll 
scale (Frisbie et al., 2009) at 1 year. Values with different superscripts differ at p < 0.01; in particular, normal letters 
a and b refer to ICRS score (blue bars), while Greek letters α and β refer to O’Driscoll scale (red bars).
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Fig. 9. Nanoindentation of goat samples at 1 year. Healthy, healthy cartilage; unload. H, Hardness as measured during 
the unloading phase; unload. E, Young’s modulus as measured during the unloading phase; load. E, Young’s modulus 
as measured during the loading phase of testing; *, samples fracture during testing; SD, standard deviation. Values 
with different superscripts differ at p < 0.05; in particular, normal letters a, b, c refer to hardness “H” (green bars), 
while Greek letters α, β, γ and δ refer to Young’s modulus determined from the loading curves “load E” (blue bars).
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then used for the in vitro explant culture and the in vivo 
implant in Group 1. Thus, the source for the repair was 
constituted of cartilage fragments originating from both 
the upper and the lower trochlear defect. This allowed for 
eliminating, both in the in vitro and the in vivo steps, any 
potential different contribution to the repair of the chips 
deriving from different trochlear sites, as pointed out by a 
recent study by Salzmann et al. (2011).
 The construct components were positioned in order to 
keep the same spatial orientation between the in vitro and in 
vivo part of the experiment, maintaining the cartilage chips 
and the fibrin glue in the middle of the construct and in 
contact with the PRFM on one side and with the HA felt on 
the opposite side. Indeed, in vivo, the PRFM was placed at 
the bottom of the goat trochlear osteochondral defects, the 
cartilage chips were wrapped in a small quantity of fibrin 
glue and placed in the middle, and the Hyaff-11 membranes 
at the top, due to the position of the defects and the gravity 
forces acting during the stance phase of the animal. For 
the in vitro part, an inverted spatial distribution was used, 
placing the Hyaff-11 membranes at the bottom of the Petri 
dishes, the mixture of chips and fibrin glue in the middle 
and the PRFM was placed at the top of the constructs.
 The in vitro results showed the natural tendency of 
chondrocytes, once freed from the surrounding matrix, 
to migrate away from cartilage chips, in a standard 
non-chondrogenic culture medium. Indeed, our findings 
confirmed the initial hypothesis that the outgrowth of 
chondrocytes, derived from chondral fragments obtained 
by mechanical fragmentation of articular cartilage, allowed 
for the production of a newly synthesised matrix around the 
fragments and inside the Hyaff felt. This neoformed tissue 
was mostly originating from the migrated chondrocytes and 
showed features similar to those of articular cartilage, such 
as the overall predominance of collagen type II staining. 
These in vitro results are consistent with two previously 
published studies by Bonasia et al. (2011), in which 
adult and juvenile chondral fragments were cultured on a 
hyaluronic acid scaffold, and Lu et al. (2006). In the latter, 
human and bovine cartilage fragments were used both in 
explant cultures and in a heterotopic implant in SCID mice, 
after being seeded in scaffolds made of polyglycolide/
non-woven felt or polyglycolide/polycaprolactone foam 
reinforced with polydiaxanone mesh, with a coating of 
fibrin glue. These observations were the premise for 
developing an in vivo cartilage fragment-based technique 
for osteochondral repair.
 Following previous evidence from preclinical animal 
models of trochlear defects in rabbits (Madry et al., 2005; 
Marmotti et al., 2012; Ueblacker et al., 2007), goats (Lu et 
al., 2006), pigs (Peretti et al., 2006), and horses (Frisbie et 
al., 2009), critically-sized trochlear osteochondral lesions 
were created to avoid spontaneous healing of smaller 
defects, as previously shown by Jackson and Ahern 
(Jackson et al., 2001; Ahern et al., 2009). This site has 
been widely used in the literature, and represents a valuable 
preclinical model being subjected both to shear forces, 
that may negatively influence the reparative process, and 
to compressive load during the stance and gait of animals, 
which have a prevalent flexed position of the stifle joint. 
Furthermore, it allows also for an easy surgical approach 
to a large area where multiple defects could be created. 
Indeed, for each unilateral trochlear model two defects 
were created at the upper and lower trochlear areas. It 
is known that patellar excursion generates different load 
bearing between the upper and lower trochlear areas 
(Salzmann et al., 2011). Thus, the three treatment groups 
(1, 2 and 3) were randomised to the two defect positions 
during the surgical procedure, in order to lessen the bias 
that could be generated by the variable loads imposed on 
the repair tissue by the patella during the tracking along the 
femoral groove, and so avoiding the potentially different 
contribution of the two defect sites to the repair process.
 A depth of 3.5 mm was chosen to simulate a human 
clinical setting of osteochondral lesions. As previously 
shown, lesions beyond 3.5 mm in goats would lead 
unquestionably to a violation of the subchondral bone 
(Hunziker, 1999b; Custers et al., 2009; Ahern et al., 
2009) during defect drilling, with extensive bleeding and 
subsequent involvement of an abundance of different cell 
types, growth factors and signalling substances from bone, 
bone marrow space and its vasculature. In this regard, the 
methodology of creating the defect can have a significant 
impact on the potential of the biological response of the 
surrounding host tissue bed. In our study, we have chosen 
a manual drill with multiple lavages. With this technique, 
defects were created in a natural way by using a slow speed 
of penetration and by removing any visible debris during 
the defect creation through continuous irrigation with 
physiological solution. This allowed for a standardisation 
of the procedure of defect creation preserving the integrity 
of the surrounding tissue, avoiding major vascular 
occlusion by debris build-up and significant temperature 
increase during defect drilling. A possible alternative would 
have been to adopt a more physio-pathological “fracture 
method” as that used in the OATS procedure, in which an 
osteochondral bone plug is fractured off the subchondral 
bone. However, even if this “fracture technique” also 
represents a good biological duplication of osteochondral 
lesions, it would have presented more difficulties in an 
experimental setting related to the standardisation of the 
method.
 In this large animal model, we verified the in vivo repair 
potential of autologous cartilage fragments embedded 
in hyaluronic acid, PRFM and fibrin glue scaffold. For 
control conditions, we used the whole scaffold alone and 
the empty defect. Although the scaffold itself was made 
by assembling different components, we have considered 
this as an entire element, and we did not further separate 
any of the single scaffold constituents into different 
control groups. Moreover, in a clinical setting, some of 
the components of the scaffold are often associated. This 
is valid, for example, for the fibrin glue with the HA 
membrane, as the fibrin acts as a biological glue for HA, 
thus representing a single complex unit. Additionally, we 
ran in parallel the in vitro and the in vivo study with the 
same design.
 Generally, a slow and incomplete overall repair process 
was observed in all groups. This is consistent with the 
cartilage repair obtained with cell-based tissue engineering 
processes (Knutsen et al., 2007; Brittberg et al., 2001). 
Up to 6 months postoperatively, immature tissue filled the 
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major part of the defects, as confirmed by the persistent 
presence of the HA membrane in both Groups 1 and 2. 
Cartilage fragments in the experimental Group 1 were 
found to be located at deeper zones of the defects already 
at the earlier time points. This was presumably due to the 
mouldable and resorbable nature of PRFM, allowing for 
a deepening of the fragments inside the matrix following 
implantation. This also implied that the fragments at the 
lower defect zone underwent a slower absorption during 
the natural bone repair process. In this regard, further 
optimisation of the implant could involve the use of a stiffer 
matrix, to obtain a more rigid supporting structure for the 
cartilage fragments, thus allowing for their homogeneous 
distribution directly under the HA sheet at the superficial 
layers of the defects. Nevertheless, we can state that the 
fragments were positively involved in the cartilage repair 
process, as the samples of Group 1 achieved an improved 
repair compared to that of the other groups at 6 months 
and 1 year. However, we cannot identify the role of these 
fragments in the entire repair process. In fact they may 
represent the cell source for the repair process, or indeed 
they could be the releasing source of conditioning factors, 
guiding the migrating cells from the surrounding tissue to 
assume a chondrocyte phenotype, or a combination of both.
 At the end of follow-up, morphological assessment 
showed no major synovial changes and only mild 
osteophyte formation in all groups, without any difference 
despite the treatment used. This suggests that the mild 
inflammatory process developed in the operated joints 
did not exert considerable influence in the osteochondral 
repair process. The end-term histological assessment of 
the defects demonstrated that cartilage fragment-loaded 
scaffolds led to a functional repair tissue with some 
hyaline-like features. Indeed, after 1 year, Group 1 showed 
an improved repair tissue with higher scores compared to 
those of the controls, with the presence of proteoglycans 
and areas of matrix positive for collagen type II. No 
relevant remnants of HA membrane were detectable at this 
period. Group 2 instead showed a persistent remodelling 
of immature repair tissue. There was, however, a slight 
chondrogenic potential of the scaffold alone, suggested 
by some small peripheral areas of matrix positive for type 
II collagen, but the overall histological appearance of 
the scaffold-alone samples at 1 year postoperatively was 
similar to that of the fibrocartilaginous healing of the empty 
defects. The difference between Group 1 compared with 
the controls suggests a key role of the minced cartilage 
fragments in the HA-PRFM-fibrin glue scaffold as being 
a source of chondrocytes and conditioning factors during 
the repair process. The better healing observed in Group 
1, however, lacked the overall zonal organisation of 
hyaline cartilage, and showed some areas of incomplete 
repair, indicating that some improvement of the technique 
is still required. Nevertheless, histological results of the 
present study represent the basis for a suitable alternative 
to the new emerging one-stage methods. Additionally, 
we cannot exclude that further tissue remodelling may 
occur in a longer follow-up, although the final result of 
the experimental Group 1 is satisfactory for a functional 
repair tissue both histologically and biomechanically.
 The biomechanical findings at 1 year showed a clear 
superiority of the Group 1 samples compared to the 
controls. A discrepancy can be noted by observing the 
greater difference between groups in the biomechanical 
tests compared to that measured by the histological scores. 
This apparent incongruence can be explained by the fact 
that the biomechanical analysis made by nanoindentation 
measured the superficial 100 µm of the samples, whereas 
the histological scores employed in this study related to 
the whole sample field. Nanoindentation was chosen to 
provide the experimental model with more sensitivity 
and resolution, compared to other clinical hand-held 
macroindentation devices. In light of these results, Group 
1 showed also the closest mechanical properties to healthy 
cartilage, while both control groups fared significantly 
worse. Nevertheless, there was a significant difference 
(p < 0.05) in the unloading curve for Hardness between 
Group 1 and healthy cartilage, confirming the substantially 
different properties of hyaline articular cartilage compared 
to that of the repair tissue derived from cartilage fragment-
loaded scaffolds at the longest time point tested. Analysis 
of Young’s modulus (E) in the loading curve does not 
contradict these previous observations, although its value 
is limited to just a slight depth of indentation, and it has 
to be considered as only being partially representative of 
the mechanical behaviour of the tissue. Compared to other 
studies (Franke et al., 2007), however, we observed overall 
greater values in H and E both for healthy cartilage and 
treated samples. This is most likely due to differences in 
hydrating conditions, sample preparation and storage of the 
specimens. This observation confirms that, in this model, 
biomechanical results should not be considered as absolute 
outcome measures for H and E, but as relative indicators 
of the quality of the different repair tissues in the different 
experimental groups compared to a corresponding area of 
healthy cartilage.
 As with other one-stage techniques, the method 
described has several hypothetical advantages for clinical 
applications. Intra-operative construct preparation is 
relatively simple, and it eliminates multiple surgeries and 
the high costs of cell culture-expansion. From a small 
biopsy, large defects could be treated by uniform tissue 
distribution into the scaffold. Natural adhesive properties 
of Hyaff-11, PRFM and fibrin glue do not need any sutures 
or staples for fixation, simplifying the surgical procedure. 
Due to the mouldable properties of this scaffold, constructs 
with minced fragments could be prepared as “paste-like” 
structures and thus be implanted arthroscopically for small 
lesions, similarly to the Hyalograft C technique (Kon et 
al., 2009).
 Some observations should be noted with regard to the 
experimental study. Firstly, compared to a human setting, 
the situation described in the in vivo part can be considered 
a “worst case” scenario for the early postoperative period, 
as the goats were allowed to freely load on the operated 
limb. Although, in a quadruped such as the goat, it is likely 
that the load of the operated limb was partially reduced 
during the first postoperative period by the spontaneous 
transfer to the other three limbs, based on the pain. On the 
other hand, in human, patients are usually invited to reduce 
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the load-bearing with crutches for the first 4 weeks in order 
to protect the implants and the early phase of the repair. 
However, this aspect did not hamper the stability of the 
implants in the treated animals, as no sign of detachment 
was seen from the histology of the euthanised animals 
in the earlier experimental time (1 month). Secondly, 
as previously mentioned, 3 animals died during the first 
45 days of follow-up and were thus excluded. However, 
this did not affect the results of the study. Indeed, the 
study itself was designed in order to describe the entire 
repair process throughout all time points, allowing for 
appreciating the differences at 1, 3, 6 and 12 months, 
especially for the experimental Group 1, and evaluating 
the final outcome of this new procedure at the longest time 
period. The number of animals and defects were sufficient 
to demonstrate a statistically relevant superiority of the 
experimental group at 1 year. Thirdly, we were not able to 
discriminate the cellular contribution to the repair process 
coming from the bone marrow, the synovial compartment 
and the cartilage surrounding the defects. In fact, due 
to the depth of the defects, cells from surrounding bone 
marrow could have migrated inside the scaffold, along 
with cells from synovial tissue and from the cartilage 
tissue at the perimeter of the defects, which could have 
adhered to the HA membrane. For this reason, different 
cell sources may have contributed to the final repair in all 3 
groups. However, this confounding factor is common to all 
specimens and had therefore not jeopardised the differences 
between groups. A future study with a labelling technique 
could be employed to analyse this particular aspect.
Conclusions
These findings suggest that cartilage fragments loaded 
into a HA-PRFM-fibrin glue scaffold may facilitate the 
repair of osteochondral defects, and represent an effective 
alternative for a non-culture-based autologous one-stage 
repair technique. Both in vitro and in vivo, cartilage-like 
matrix was observed in the presence of chondral fragment-
loaded scaffolds, suggesting that cartilage fragments 
represent a potential cell source for one-step procedures. 
Before clinical application, further studies are necessary in 
order to confirm the underlying mechanisms of this repair 
technique, both in a more mechanically challenging site, 
as in the medial femoral condyle, and in chronic lesions, 
which could respond differently to repair procedures and 
represent a more clinically relevant setting.
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Discussion with Reviewer
Reviewer II: Cells contributing to the in vivo repair could 
be recruited from the implanted scaffolds or the surrounding 
tissues or both – do you see ways of differentiating the roles 
of these cell populations?
Authors: This is an interesting question, focusing on one 
of the main observations of our in vivo study. Indeed, in the 
goat model the contribution to the repair may be derived 
both from the cells implanted by the scaffolds and from 
the surrounding tissues, such as the bone marrow, the 
synovial compartment and the cartilage surrounding the 
defects. In the literature, different studies have proposed 
a cell labelling technique to assess the location and the 
role of specific cell populations at the defect site, but this 
seems to be somehow impractical for our repair model, 
dealing with cartilage fragments embedded in a composite 
scaffold as a source of cells for the repair. On the other 
hand, a male source of fragments implanted in a female 
host could represent a possible solution to that issue, due to 
the possibility to detect cells carrying the Y gene sequence 
in the repair tissue by in situ hybridisation, as suggested 
by recent work of Dattena et al. (2009). Indeed, the use of 
scaffold with allogeneic chondral fragments transplanted to 
recipients of different gender may constitute an alternative 
to identify the position of the migrating chondrocytes in 
the repair tissue and to discriminate this particular cell 
population from the recipient cells of the surrounding 
tissue.
Reviewer II: The constructs consist of an array of 
components that due to their commercial source may 
have limited general and long-term availability. Can you 
speculate which components have the most favourable 
impact on healing and reversely which components could 
be left out or replaced with non-proprietary materials?
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Authors: The use of a composite scaffold has several 
advantages linked to the different properties of the 
components, and the choice of a commercially available 
source for the materials has, potentially, the clinical 
relevance of a “direct” application of the same tools. The 
Reviewer’s observation is entirely appropriate because it 
is well known that commercial materials can be withdrawn 
for different reasons, spanning from commercial politics 
to emerging technologies that are offered in place of the 
previous components. We believe that two components are 
fundamental for the repair driven by cartilage fragments. 
The first is the fibrin glue. It allows the fragments to be 
bound together, stabilising the construct for the first phases 
of the repair, and facilitates the migration/outgrowth of 
chondrocytes toward the outer space through the fibrin 
net. This makes fibrin glue optimal for embedding cells for 
cartilage repair, also considering the possibility to modulate 
the formation of the “pores” simply by changing the 
concentration of the thrombin before the formation of the 
fibrin net. Besides, fibrin glue has also been proposed in the 
literature as a single scaffold for autologous chondrocyte 
implantation because of its peculiar properties (Bekkers 
et al., 2013; Wysocka A et al., 2010). However, the issue 
of the commercial availability of the fibrin glue could be 
simply solved in a potential clinical setting by preparing 
autologous fibrin glue from the blood of the patients or, 
as an alternative, by using allogeneic fibrinogen from 
voluntary donors stored in the local blood centre.
 The second important component of the scaffold 
is certainly the HYAFF-11 membrane. The properties 
of a hyaluronic acid felt go beyond the simple action 
of “coverage” of a lesion, because the acid itself has 
chondrogenic properties and can positively influence the 
formation of cartilaginous tissue (Cavallo et al., 2010). 
The ease of application of this membrane makes this 
component very useful, being an “active” coverage of 
the osteochondral defect. Moreover, in different clinical 
papers, HYAFF-11 has already been used as a scaffold for 
one-stage cartilage repair together with bone marrow and 
platelet-rich plasma (Giannini et al., 2009; Buda et al., 
2010). However, in the unlikely event HYAFF-11 being 
no longer available, another biological scaffold could be 
used as a substitute. The collagen I/III membranes used for 
the MACI technique (i.e. ChondroGide®) may perform as 
well for the coverage of the defects, although its structure 
is more rigid and less permeable than that of the HYAFF 
felt. The bottom of the goat defects in our study was filled 
with a platelet-derived gel classified as “Platelet-rich-
fibrin-matrix” (PRFM). This is the third component of the 
construct. It was chosen to fill the bottom of the defects for 
the malleability associated with a short-term delivery of 
growth factors. This type of platelets derivative is largely 
used in clinical settings. Some impact, in the very first 
phases of the healing process, may derive from the release 
of the growth factors stored in the platelets. However, the 
main action of this type of PRFM lies probably on the tri-
dimensional structure of the fibrin network that is slowly 
resorbed and substituted by the host bone. If not available, 
it can be easily substituted for by more rigid components 
such as the demineralised bone matrix chips or, in case 
of superficial defects not involving major portions of the 
subchondral bone, it could be left out – provided that a 
sufficient filling is guaranteed by the other components of 
the constructs.
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